Moro, Loredana http://orcid.org/0000-0002-5111-3465
Simoneschi, Daniele http://orcid.org/0000-0003-0448-4295
Kurz, Emma
Arbini, Arnaldo A.
Jang, Shaowen
Guaragnella, Nicoletta
Giannattasio, Sergio http://orcid.org/0000-0001-5559-5556
Wang, Wei
Chen, Yu-An
Pires, Geoffrey
Dang, Andrew
Hernandez, Elizabeth
Kapur, Payal
Mishra, Ankita
Tsirigos, Aristotelis http://orcid.org/0000-0002-7512-8477
Miller, George http://orcid.org/0000-0001-8482-4100
Hsieh, Jer-Tsong
Pagano, Michele http://orcid.org/0000-0003-3210-2442
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA168611, CA215471, CA206105, CA76584)
The Pancreatic Cancer Action network Translational Research Grant
Article History
Received: 6 May 2019
Accepted: 14 July 2020
First Online: 24 August 2020
Competing interests
: M.P. has financial interests in CullGen Inc. and Kymera Therapeutics. M.P. is on the SAB of CullGen Inc. and Kymera Therapeutics. M.P. is a consultant for BeyondSpring Pharmaceuticals, CullGen Inc., Kymera Therapeutics, Exo Therapeutics and SEED Therapeutics. The other authors declare no competing interests.